What is Reunion RX?
Reunion RX operates as an independent pharmacy provider with a strong presence in New Jersey's long-term care industry, boasting over two decades of experience. The company distinguishes itself through a commitment to operational and clinical excellence, prioritizing customer satisfaction and building trust with its clients. Its seasoned management team focuses on assisting facilities in navigating the complexities of the pharmacy service market, offering a personalized approach that sets it apart in the healthcare landscape.
How much funding has Reunion RX raised?
Reunion RX has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Reunion RX
PPP
Public-Private Partnership
What's next for Reunion RX?
The substantial late-stage funding indicates Reunion RX is poised for significant growth and strategic scaling. This capital is likely to be deployed towards expanding its service offerings, enhancing its technological infrastructure, and potentially increasing its geographic footprint. The company's focus on operational efficiency and clinical excellence, combined with this recent financial backing, positions it to further solidify its market share and address the evolving needs of long-term care facilities.
See full Reunion RX company page
